← All candidates
No insider filings on record.
5 filings on record.
PYXSPyxis Oncology, Inc.
NasdaqGS · Healthcare · $278.58M
$3.34
-2.92% · Sep 15
No insider filings on record.
Pyxis Oncology, Inc. hasn't reported Form 4 activity yet.
Price · 1Y · dailyNo open-market activity in range
▸ hover a marker for the filing · drag to zoom · 4 moves explained
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Market cap
$278.58M
Float
49.6M
59% public
Short % float
Pro
Price / profit
—
not yet profitable
Price / future profit
—
Price / sales
25.2
Institutional stakes
▸ a holder crossing 5% files Schedule 13D if they intend to act on the company, 13G if they certify they will not · /A amends an earlier filing
2 filingsnewest first
The record
newest first
No insider transactions on file for PYXS yet.
Context
Coverage
Pyxis Oncology shares fall 7% despite updated MICVO trial resultsInvestorsHub · 1w agoPyxis Oncology Secures Up to $114 Million Private PlacementMT Newswires · 06-30Analysts See Nearly 3X Upside in Pyxis Oncology (PYXS)Insider Monkey · 06-10Creative Global Technology Holdings And 2 Other Promising Penny StocksSimply Wall St. · 05-12
The file stays open
5 filings on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice